Pharmaceutical Technology ePT Weekly:
Having trouble viewing this e-mail? Click here.
ePT by PharmTech logo
News
Product Spotlight
Industry Briefs
PharmTech,
the magazine

Advertisement

About Us

Subscribe to Pharmaceutical Technology

Whitepaper Library

Podcasts

Webcast: Risk Management in Sterile Manufacturing
September 27, 2012—Sponsored by DPT

Webcast: Increasing Your Chances for Success in First-In-Man Studies
October 3, 2012—Sponsored by Patheon

Webcast: Overcoming Challenges with Pediatric Oral Solid Dose Development
October 3, 2012—Sponsored by Colorcon

Webcast: Achieving Sensory Benefits and Mildness in Dermatology Products
October 4, 2012—Sponsored by BASF

MORE WEBCASTS

Podcast: Topical Drug Development for Dermatology Products

Podcast: The Awesome Power of Virtual "Quality" in a Regulated Environment

MORE PODCASTS

Events

Biological Production Forum
September 24, 2012–September 26, 2012
Dusseldorf, Germany

10th Anniversary Cold Chain & Temperature Global Management Forum
September 24, 2012–September 28, 2012
Chicago, Illinois

Downstream Technology Forum Cambridge
September 26, 2012
Cambridge, Massachusetts

INTERPHEX Puerto Rico 2012
October 4, 2012–October 5, 2012
San Juan, Puerto Rico

CPhI Worldwide
October 9, 2012–October 11, 2012
Madrid, Spain

More events


FindPharma Search
September 20, 2012 PharmTech.com

Confirm your ePT Weekly subscription
We noticed you haven’t opened your ePT Weekly in quite a while.  While we don’t want to lose you as a valuable reader, we understand that preferences change.  If you would like to continue receiving ePT Weekly, please take a moment to confirm your subscription by clicking here.

If you have had trouble receiving your ePT Weekly, be sure to add our new email address pharmtech@advanstarpharmtch.com to your address book or safe sender list to ensure delivery.

Thank you,
Pharmaceutical Technology Staff

P.S. You can also use this form to subscribe to other informative e-newsletters from Pharmaceutical Technology – just click here to sign up today!



News

Bayer HealthCare Acquires Teva's US Animal Health Business
Teva announced an agreement in which Bayer HealthCare will acquire the US-based animal health business of Teva Pharmaceutical Industries for up to $145 million. The transaction is expected to close in 2013, subject to antitrust clearance and other conditions.
Click Here to Read More

J&J to Establish Innovation Centers
Johnson & Johnson has announced plans to open four innovation centers in California, Boston, London, and China, with the aim of accelerating early innovation and facilitating collaboration and investment opportunities.
Click Here to Read More

Potential European Pharmacovigilance Fees Criticized
The European Generic Medicines Association has raised concerns about the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities.
Click Here to Read More

Advertisement:
Pharmaceutical starches from Grain Processing Corporation (GPC) range from basic unmodified starches for tableting to very specialized, innovative starches for unique applications.  Spress® Pregelatinized Corn Starches NF perform as binders, disintegrants and lubricants for granulations, direct-compression tablets, capsules, dry blends and roller compaction.  PURE-COTE® film-forming starches are designed for coating applications, oral thin films, capsules and any applications where clear, flexible films are required. Read More



Product Spotlight

Bench top microwave digestion system for trace-metals analysis for USP <232> and <233>

Milestone’s UltraWAVE is a benchtop microwave system that uses Single Reaction Chamber (SRC) technology to improve the sample-prep workflow for trace-metals analysis by ICP-MS/OES. The system is offered as a replacement option for both traditional open-vessel and closed-vessel digestion systems in pharmaceutical laboratories, and can enhance efficiency by increasing sample throughput while lowering labor costs. Unlike traditional digestion systems, the SRC can process multiple sample types simultaneously, and up to 15 samples can be digested at one time in less than an hour from start to finish. The unit can also handle large sample weights (5 x 2 g), previously only possible with open vessel digestion. The high-temperature (300 °C) and high-pressure (199 bar) capabilities of the UltraWAVE can also result in more complete digestions and better analytical data quality.

Company Notes

Pfizer and the Chinese pharmaceutical company Zhejiang Hisun Pharmaceuticals have launched Hisun-Pfizer Pharmaceuticals, a joint venture formed between the two companies to develop, manufacture, and commercialize off-patent pharmaceutical products in China and global markets. Read More

Advertisement:
Free Technical Posters for Tablet Manufacturers
The latest edition to Natoli's extensive collection of free technical resources, the Technical Poster Series features 3 large-format posters packed with helpful tips, charts, terminology, and more. For a limited time, all 3 posters are available at no charge — shipping included — so order yours now! http://www.natoli.com/Posters-PT.html

On Sept. 12, 2012, Sartorius opened its new facility in Guxhagen, Germany, for the manufacture of bioreactors following a one-year, EUR 18-million ($23.5 million) construction project. The 100,000-ft2 complex will serve clients in the biopharmaceutical industry and provide space for a high-tech manufacturing hall and offices for around 240 employees. Read More

Advertisement:
Realize Effective Pharmaceuticals
Reliable solutions enable pharmaceutical scientists to innovate in disease research, accelerate drug discovery and have greater confidence throughout development and manufacturing. Agilent solutions in genomics research, automation, separation and detection technologies along with workflow driven software solutions helps deliver the answers to bring effective therapeutics to market www.agilent.com/lifesciences/realizepharma

Xcelience opened its new 24,000-ft2 facility in Tampa, Florida, on Sept. 14, 2012. The building will be used for primary and secondary packaging, labeling, distribution, and warehouse services. This is the company’s second facility in the Tampa Bay area, and the company says it will be audited and approved for domestic as well as European clinical trials. Read More

Advertisement:
Agilent ICP-MS/ICP-OES
Reliable solutions for regulated pharmaceutical laboratories
Complying with new elemental impurity limits as defined by draft USP methods <232>/<233> could pose a significant challenge. You need to choose qualified hardware and software, ensure verification, and maintain electronic records. But there is a simple answer – Request a free copy of our primer on Elemental Impurity Analysis to learn more.

A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More

Advertisement:
Risk Management in Sterile Manufacturing
WEBCAST: Thursday, September 27, 2012 from 2:00 PM - 3:00 PM EDT
Register Free at http://www.pharmtech.com/dpt2

Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com


Advertisement:
Overcoming Challenges with Pediatric Oral Solid Dose Development Live Webcasts: Wednesday, October 3, 2012 at 3:00 pm IST (India Standard Time) and 10:00 am EDT (Eastern Daylight Time)
Register Free at www.pharmtech.com/oralsolid

PharmTech, the magazine
Current Issue cover
Correlating Product Lifecycle and Manufacturing Site Characteristics with Critical-to-Quality Product Deviations
by: Reuben D. Domike, Jeffrey T. Macher, Paul W. Barone, Stacy L. Springs, Anthony J. Sinskey, Scott Stern
MIT survey results address product and site characteristics that statistically correlate with quality performance.
Click Here to Read More

Please participate in MIT’s Biopharmaceutical Manufacturing Site Study. The purpose of the study is to examine the effect of globalization on biopharmaceutical product manufacturing quality approaches and how firms organize around quality activities.


Coming soon: Pharm Tech's October issue will feature peer-reviewed research on quality-by-design for analytical methods.


Advertisement:
Achieving Sensory Benefits and Mildness in Dermatology Products
Live Webcast: Thursday, October 4, 2012 at 10:00 AM EDT
Register Free at www.pharmtech.com/sensory


Know Before You Go—2012 Conference Previews

Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.

Find company backgrounds, new product releases, booth materials, and more.

PharmTech's online Gateway is your guide to the season's leading shows.



Advertisement:
Increasing your chances for success in First-In-Man studies
Live Webcast: Wednesday, October 3, 2012 at 11:00 AM EDT
Register Free at www.pharmtech.com/success

 

PharmTech Poll

European Pharmacovigilance Activities
The European Generic Medicines Agency has recently claimed that the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities are unjustifiably high. Do you agree?

Vote here
View the poll archive.
 
On Our Blog PharmTech Talk

>>Recent Posts

Regulation
GDUFA's Effect on Drug Master Files

Outsourcing, R&D, Trends
MIT Survey Aims to Correlate Product Lifecycle and Manufacturing Site Characteristics with Product Deviations

Industry Conferences, R&D
PhRMA Awards Ceremony Inspiring for Alzheimer's Workers, Researchers

>>Go to the Blog Homepage

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |

Visit PharmTech.com Visit PharmTech.com About Us Subscribe Today! Start your RSS subscription today! Manufacturing Outsourcing Formulation Ingredients Testing Drug Delivery IT Packaging Regulation Visit PharmTech.com